Search

everythinglearnresearchcommunity

for

Search:↓

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Depression worsens eczema severity, increases inflammation, and lowers quality of life.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

Skin has a larger surface area than thought, certain skin cells improve skin flap survival, better trials for skin conditions in children are needed, Stevens-Johnson syndrome rates vary by age and race, and better skin barrier function may reduce inflammation in the elderly.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Adipose-derived stem cells may help treat hair loss.

Understanding keratinization is crucial for treating skin conditions like ichthyoses and psoriasis.

The document discusses various skin disorders and new therapeutic approaches.

Alopecia areata may be treated by targeting immune system imbalances.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

The study found that skin inflammation and immune response pathways are activated in Solar Urticaria patients after UV exposure, unlike in healthy people.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.

Bimekizumab effectively treated a man's chronic beard hair loss.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Some eczema treatments may cause conjunctivitis, many people have sensitive eyes, air pollution can increase skin wrinkles, hair loss medication does not affect sexual function, and dermatologists can help identify torture signs on refugees' skin.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

miR-21 helps improve ovarian function recovery in treated mice.

Probiotics may help improve symptoms in rheumatoid arthritis patients.

Lygodium japonicum spores can reduce inflammation by blocking certain cell signals.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Targeting macrophages may improve wound healing.